2022
DOI: 10.1016/j.jep.2022.115489
|View full text |Cite
|
Sign up to set email alerts
|

Aesculetin exhibited anti-inflammatory activities through inhibiting NF-кB and MAPKs pathway in vitro and in vivo

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
11
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 24 publications
(15 citation statements)
references
References 43 publications
0
11
0
Order By: Relevance
“…In addition, a recent study indicated that esculetin was also able to inhibit the activation of NLR family pyrin domain containing 3 inflammasome in LPSinduced RAW264.7 cells. [78] Other in vivo experiments have similarly confirmed the anti-inflammatory activity of esculetin. In LPS-induced mice with acute lung injury, pretreatment with esculetin (20 and 40 mg/kg) significantly attenuated LPS-induced histopathologic changes, decreased inflammatory cell infiltration, and reduced the production of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in lung tissue.…”
Section: Anti-inflammatory Activity Of Esculetinmentioning
confidence: 81%
“…In addition, a recent study indicated that esculetin was also able to inhibit the activation of NLR family pyrin domain containing 3 inflammasome in LPSinduced RAW264.7 cells. [78] Other in vivo experiments have similarly confirmed the anti-inflammatory activity of esculetin. In LPS-induced mice with acute lung injury, pretreatment with esculetin (20 and 40 mg/kg) significantly attenuated LPS-induced histopathologic changes, decreased inflammatory cell infiltration, and reduced the production of pro-inflammatory cytokines (TNF-α, IL-1β, and IL-6) in lung tissue.…”
Section: Anti-inflammatory Activity Of Esculetinmentioning
confidence: 81%
“…Wang et al [ 85 ] considered aesculetin, a coumarin derivative extracted from the bark of Fraxinus rhynchopylla , to investigate its effects in activating the NF-kB pathway and MAPKs in vivo and in vitro model of colitis. In vitro, before treatment, there was an increase in NO, iNOS expression, p–NF–κB-P65 expression, NF-kB P65 nuclear translocation, p38 phosphorylation, JNK phosphorylation, ERK phosphorylation, and NLRP3 expression.…”
Section: Discussionmentioning
confidence: 99%
“…In the same experimental model of intestinal inflammation using C57BL/6 female mice, esculetin orally administered at 20 mg/Kg ameliorated intestinal injury, decreased MPO activity and IL-6 and TNF-α production, and inhibited NF-κB/MPAKs signaling pathways [82]. The inhibitory action of the NF-κB activation, p38, JNK, and extracellular signal-regulated kinase (ERK) phosphorylation, and IL-6, nitric oxide (NO), and TNF-α production were corroborated in RAW264.7 cells treated with 10, 25 and 50 µM of esculetin [82].…”
Section: Esculetin 4-methylesculetin and Esculinmentioning
confidence: 94%